← Back to Search

Behavioural Intervention

Diabetes Education App for Type 2 Diabetes

Led By Luis A Murillo, MD, MPH
Research Sponsored by The Reading Hospital and Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of Type 2 Diabetes with HA1c >8.0
Age ≥ 18 years
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial will study how an app can help people with diabetes manage their condition better & improve health outcomes.

Who is the study for?
This trial is for adults over 18 with uncontrolled Type 2 Diabetes (HA1c >8.0) who are patients at the Family Healthcare Center, Reading Hospital Tower Health. It's not for pregnant individuals, incarcerated people, those without a smartphone, or anyone unable to consent.Check my eligibility
What is being tested?
The study tests a diabetes education app that provides videos on managing diabetes and lifestyle changes versus usual care without the app. The impact on blood sugar control (HA1C), body weight, blood pressure, and self-management confidence is measured.See study design
What are the potential side effects?
Since this intervention involves educational content rather than medication or invasive procedures, no direct medical side effects are expected from using the mobile web application.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
I have Type 2 Diabetes with an HA1c level above 8.0.
I am 18 years old or older.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
"Self-Efficacy for Diabetes Scale"
Hemoglobin A1c
Secondary outcome measures
Blood pressure
Body Mass Index

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention armExperimental Treatment1 Intervention
Participants enrolled in the intervention arm will be given a 6-month access period to the diabetes education application designed by the study team. The web site will offer videos related to a specific areas of education concerning diabetes self-management. To encourage compliance, participant users will receive weekly notifications from the application that will guide them through viewing all videos in the series. Participants will continue routine follow-up appointments with their primary care physicians during the study period. There will be no restrictions on starting or stopping medications during the study period.
Group II: Control armActive Control1 Intervention
Participants in the control arm will not have access to the Diabetes Application. They will continue follow-up appointments according to the standard of care with their primary care physician, diabetic educators, etc. There are no restrictions on starting or stopping medications for patients within the control arm.

Find a Location

Who is running the clinical trial?

The Reading Hospital and Medical CenterLead Sponsor
13 Previous Clinical Trials
1,416 Total Patients Enrolled
Reading Hospital FoundationUNKNOWN
Complete Statistical Services (Consult-Stat)UNKNOWN

Media Library

Diabetes education web site application (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05893927 — N/A
Type 2 Diabetes Research Study Groups: Intervention arm, Control arm
Type 2 Diabetes Clinical Trial 2023: Diabetes education web site application Highlights & Side Effects. Trial Name: NCT05893927 — N/A
Diabetes education web site application (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05893927 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still openings for enrolment in this research project?

"According to the information hosted on clinicaltrials.gov, enrollment for this medical study has closed as of May 30th 2023. Consequently, it is no longer looking for participants; however, there are 1403 other trials that currently require volunteers."

Answered by AI
~80 spots leftby Sep 2025